Related Experiment Video
Updated: Jun 7, 2026
07:52
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Cardiorenal dysfunction
1Society of Chest Pain Centers, Columbus, Ohio, USA. smm375@yahoo.com
AACN Advanced Critical Care
|November 4, 2010
Summary
Cardiorenal syndrome (CRS) involves heart and kidney dysfunction, often coexisting and increasing mortality. This review clarifies CRS pathophysiology, classification, and updated therapeutic strategies.
Area of Science:
- Cardiology
- Nephrology
- Internal Medicine
Background:
- Left ventricular dysfunction and renal dysfunction are prevalent chronic conditions.
- These conditions frequently coexist, leading to significant morbidity and mortality.
- The bidirectional interaction between cardiac and renal systems forms the basis of cardiorenal syndrome (CRS).
Purpose of the Study:
- To present the pathophysiology of cardiorenal syndrome (CRS).
- To introduce a new classification system for different types of CRS.
- To discuss therapeutic interventions and novel therapies for CRS.
Main Methods:
- Review of the pathophysiology of cardiorenal syndrome.
- Presentation of a new classification for cardiorenal syndrome.
- Discussion of therapeutic interventions based on the 2010 Acute Dialysis Quality Initiative consensus.
Main Results:
- Cardiorenal syndrome (CRS) pathophysiology is complex, involving bidirectional organ interactions.
- A new classification system aids in understanding and diagnosing different CRS types.
- Current and novel therapeutic strategies are being developed for effective CRS management.
Conclusions:
- Understanding cardiorenal syndrome (CRS) is crucial for managing patients with coexisting heart and kidney dysfunction.
- The new classification provides a framework for diagnosis and treatment.
- Ongoing research and updated recommendations offer hope for improved patient outcomes.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:28Cardiac Catheterization I: Pre-Procedure Overview
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...